Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis
Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis
复制标题
DOI：
10.1155/2012/595427
复制
发表时间：
2012-01-01
影响因子：
--
通讯作者：
Hunfeld, K. -P.
中科院分区：
文献类型：
--
作者：
Mueller, I.;Freitag, M. H.;Hunfeld, K. -P.
背景关于莱姆病（LB）对欧洲卫生保健系统的经济影响的数据很少。该项目主要关注德国LB患者的流行病学和实验室检测费用。材料和方法。我们对2007年和2008年的流行病学和医学经济学数据进行了哨点分析。数据由一家德国法定健康保险公司（DAK）提供，覆盖约100万人。6.04百万会员。此外，还研究了德国LB诊断检测的质量。结果2007年和2008年，在604万名投保人中，平均有15 742人（0.26%）被诊断为LB。每年为这些患者订购20，986个EIA和12，558个免疫印迹。对于门诊部门的所有投保人，每年向保健提供者报销174 820次环境影响评估和52 280次免疫印迹（费用：2 600 850英镑（原文如此））。对于德国，预计费用总额估计为51 215 105英镑。然而，能力测试数据质疑测试质量和标准化的诊断分析使用。结论这项研究的结果表明，正在进行的问题有关的护理LB，并可能有助于改善未来的LB疾病的管理。
Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods. We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. Results. In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850(sic)). For Germany, the overall expected cost is estimated at 51,215,105(sic). However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Conclusion. Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.